Back to Search
Start Over
Clinical Trial Transparency: The FDA Should and Can Do More
- Source :
- Journal of Law, Medicine & Ethics. Winter, 2017, Vol. 45 Issue 4, pS33, 6 p.
- Publication Year :
- 2017
-
Abstract
- In recent years, the scientific community and regulators have increasingly recognized the value of data transparency in clinical research. Adding to this momentum, the Blueprint for Transparency at the FDA [...]
- Subjects :
- United States. Food and Drug Administration -- Powers and duties -- Information management -- Standards
Clinical trials -- Access control -- Laws, regulations and rules
Public interest law -- Evaluation -- Influence -- Health aspects -- Remedies
Administrative discretion -- Laws, regulations and rules -- Management
Exemptions (Law) -- Laws, regulations and rules
Freedom of information -- Laws, regulations and rules -- Remedies
Government regulation
Company business management
Company systems management
Health
Law
Freedom of Information Act
Subjects
Details
- Language :
- English
- ISSN :
- 10731105
- Volume :
- 45
- Issue :
- 4
- Database :
- Gale General OneFile
- Journal :
- Journal of Law, Medicine & Ethics
- Publication Type :
- Periodical
- Accession number :
- edsgcl.528197864